Correction to: Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment

[1]  P. Tugwell,et al.  Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment , 2017, Health and Quality of Life Outcomes.

[2]  Elie A Akl,et al.  A methodological survey identified eight proposed frameworks for the adaptation of health related guidelines. , 2017, Journal of clinical epidemiology.

[3]  G. Guyatt,et al.  GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines , 2016, British Medical Journal.

[4]  Gordon H Guyatt,et al.  GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction , 2016, British Medical Journal.

[5]  Charles King,et al.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2016, Arthritis & rheumatology.

[6]  M. Dougados,et al.  Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update , 2015, Annals of the rheumatic diseases.

[7]  Christopher J Cates,et al.  Assessing the methodological quality of systematic reviews , 2015, npj Primary Care Respiratory Medicine.

[8]  Anita Patel,et al.  Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial , 2015, BMJ : British Medical Journal.

[9]  P. Geusens,et al.  Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial , 2014, Annals of the rheumatic diseases.

[10]  R. Sharma,et al.  Comparison of intra-articular glucocorticoid injections with DMARDs versus DMARDs alone in rheumatoid arthritis. , 2014, The Journal of the Association of Physicians of India.

[11]  Romina Brignardello-Petersen,et al.  Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise , 2014, Canadian Medical Association Journal.

[12]  Laure Gossec,et al.  Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis , 2014, Annals of the rheumatic diseases.

[13]  C. Allaart,et al.  A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study , 2013, Annals of the rheumatic diseases.

[14]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[15]  B. Fervers,et al.  Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation , 2011, Quality and Safety in Health Care.

[16]  France Légaré,et al.  Adapting clinical practice guidelines to local context and assessing barriers to their use , 2010, Canadian Medical Association Journal.

[17]  H. Schünemann,et al.  A vision statement on guideline development for respiratory disease: the example of COPD , 2009, The Lancet.

[18]  Alonso Carrasco-Labra,et al.  GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. , 2017, Journal of clinical epidemiology.

[19]  R. Westhovens,et al.  Two-year clinical and radiologic follow-up of early RA patients treated with initial step up monotherapy or initial step down therapy with glucocorticoids, followed by a tight control approach: lessons from a cohort study in daily practice , 2013, Clinical Rheumatology.

[20]  S. Greenfield,et al.  Clinical practice guidelines we can trust , 2011 .